Drug Shortage Report for GD-GABAPENTIN
| Report ID | 33910 |
| Drug Identification Number | 02285843 |
| Brand name | GD-GABAPENTIN |
| Common or Proper name | GD-GABAPENTIN |
| Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100's |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-01-02 |
| Estimated end date | |
| Actual end date | 2018-02-05 |
| Shortage status | Resolved |
| Updated date | 2018-02-07 |
| Company comments | Please note that only 1 lot with an expiry date of 6/30/2018 remains available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-02-07 | French | Compare |
| v6 | 2018-02-07 | English | Compare |
| v5 | 2018-01-19 | French | Compare |
| v4 | 2018-01-19 | English | Compare |
| v3 | 2018-01-05 | English | Compare |
| v2 | 2017-12-20 | French | Compare |
| v1 | 2017-12-20 | English | Compare |
Showing 1 to 7 of 7